rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
11
|
pubmed:dateCreated |
1994-12-29
|
pubmed:abstractText |
Intrathecal chemotherapy, radiation therapy, and systemic chemotherapy are used for both prophylaxis and treatment of central nervous system (CNS) disease in hematologic malignancies. Twenty-three cases of myelopathy that occurred in patients who received intensive CNS-directed therapy were evaluated to identify the determinants of this severe CNS toxicity.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0008-543X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
74
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3034-41
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:7954266-Adolescent,
pubmed-meshheading:7954266-Adult,
pubmed-meshheading:7954266-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7954266-Burkitt Lymphoma,
pubmed-meshheading:7954266-Child,
pubmed-meshheading:7954266-Child, Preschool,
pubmed-meshheading:7954266-Cytarabine,
pubmed-meshheading:7954266-Female,
pubmed-meshheading:7954266-Humans,
pubmed-meshheading:7954266-Male,
pubmed-meshheading:7954266-Methotrexate,
pubmed-meshheading:7954266-Radiotherapy,
pubmed-meshheading:7954266-Spinal Cord,
pubmed-meshheading:7954266-Spinal Cord Neoplasms,
pubmed-meshheading:7954266-Spinal Diseases,
pubmed-meshheading:7954266-Thiotepa
|
pubmed:year |
1994
|
pubmed:articleTitle |
Excessive spinal cord toxicity from intensive central nervous system-directed therapies.
|
pubmed:affiliation |
Children's Hospital, St. Paul, MN 55105.
|
pubmed:publicationType |
Journal Article,
Review,
Case Reports,
Research Support, Non-U.S. Gov't
|